| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918080 | Radiotherapy and Oncology | 2015 | 7 Pages |
Abstract
Concurrent low dose CTRT can be an effective treatment modality in advanced and incurable HNSCC. However, a larger phase III trial is required.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Arvind Kumar, Atul Sharma, Bidhu Kalyan Mohanti, Alok Thakar, Nootan Kumar Shukla, Sanjay P. Thulkar, Kapil Sikka, Suman Bhasker, Chirom Amit Singh, Sreenivas Vishnubhatla,